Ming Yan - 03 Feb 2023 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)

Role
Chief Technology Officer, Director
Signature
/s/ Valerie Barnett, Attorney-in-Fact for Ming Yan
Issuer symbol
CTKB
Transactions as of
03 Feb 2023
Net transactions value
-$14,742
Form type
4
Filing time
07 Feb 2023, 17:31:09 UTC
Previous filing
20 Jan 2023
Next filing
10 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTKB Common Stock Sale $14,594 -1,081 -0.01% $13.50 7,945,752 03 Feb 2023 Direct F1
transaction CTKB Common Stock Sale $149 -11 -0% $13.51 7,945,741 03 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2022.